IRIS Accounts Production v25.1.3.33 02333663 Board of Directors Board of Directors Board of Directors Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh023336632024-03-31023336632025-03-31023336632024-04-012025-03-31023336632023-03-31023336632023-04-012024-03-31023336632024-03-3102333663ns15:EnglandWales2024-04-012025-03-3102333663ns14:PoundSterling2024-04-012025-03-3102333663ns10:Director12024-04-012025-03-3102333663ns10:Director22024-04-012025-03-3102333663ns10:Director32024-04-012025-03-3102333663ns10:Director42024-04-012025-03-3102333663ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3102333663ns10:SmallEntities2024-04-012025-03-3102333663ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3102333663ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3102333663ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3102333663ns10:FullAccounts2024-04-012025-03-310233366312024-04-012025-03-3102333663ns10:CompanySecretary12024-04-012025-03-3102333663ns10:RegisteredOffice2024-04-012025-03-3102333663ns5:CurrentFinancialInstruments2025-03-3102333663ns5:CurrentFinancialInstruments2024-03-3102333663ns5:Non-currentFinancialInstruments2025-03-3102333663ns5:Non-currentFinancialInstruments2024-03-3102333663ns5:ShareCapital2025-03-3102333663ns5:ShareCapital2024-03-3102333663ns5:RevaluationReserve2025-03-3102333663ns5:RevaluationReserve2024-03-3102333663ns5:RetainedEarningsAccumulatedLosses2025-03-3102333663ns5:RetainedEarningsAccumulatedLosses2024-03-3102333663ns5:NetGoodwill2024-04-012025-03-3102333663ns5:LandBuildings2024-04-012025-03-3102333663ns5:PlantMachinery2024-04-012025-03-3102333663ns5:NetGoodwill2024-03-3102333663ns5:NetGoodwill2025-03-3102333663ns5:NetGoodwill2024-03-3102333663ns5:LandBuildings2024-03-3102333663ns5:PlantMachinery2024-03-3102333663ns5:LandBuildings2025-03-3102333663ns5:PlantMachinery2025-03-3102333663ns5:LandBuildings2024-03-3102333663ns5:PlantMachinery2024-03-3102333663ns5:CostValuation2024-03-3102333663ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3102333663ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3102333663ns5:RevaluationReserve2024-03-31
REGISTERED NUMBER: 02333663 (England and Wales)














CHEMODEX LIMITED

Unaudited Financial Statements

for the Year Ended 31 March 2025






CHEMODEX LIMITED (REGISTERED NUMBER: 02333663)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CHEMODEX LIMITED

Company Information
for the Year Ended 31 March 2025







DIRECTORS: L Armstrong
C Armstrong
M Armstrong
C Birch





SECRETARY: A Armstrong





REGISTERED OFFICE: Canal Road
Worksop
Nottinghamshire
S80 2EH





REGISTERED NUMBER: 02333663 (England and Wales)






CHEMODEX LIMITED (REGISTERED NUMBER: 02333663)

Balance Sheet
31 March 2025

2025 2024
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 771,486 758,931
Investments 6 - -
771,486 758,931

CURRENT ASSETS
Stocks 134,724 129,541
Debtors 7 854,083 889,355
Investments 8 35,000 35,000
Cash at bank 75,632 302,262
1,099,439 1,356,158
CREDITORS
Amounts falling due within one year 9 1,053,501 1,018,864
NET CURRENT ASSETS 45,938 337,294
TOTAL ASSETS LESS CURRENT
LIABILITIES

817,424

1,096,225

CREDITORS
Amounts falling due after more than one
year

10

(142,614

)

(194,663

)

PROVISIONS FOR LIABILITIES (192,871 ) (180,089 )
NET ASSETS 481,939 721,473

CHEMODEX LIMITED (REGISTERED NUMBER: 02333663)

Balance Sheet - continued
31 March 2025

2025 2024
Notes £    £    £   
CAPITAL AND RESERVES
Called up share capital 17,340 17,340
Fair Value Reserve 11 75,976 75,976
Retained earnings 388,623 628,157
SHAREHOLDERS' FUNDS 481,939 721,473

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 July 2025 and were signed on its behalf by:




L Armstrong - Director C Armstrong - Director




M Armstrong - Director C Birch - Director


CHEMODEX LIMITED (REGISTERED NUMBER: 02333663)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Chemodex Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2004, is being amortised evenly over its estimated useful life of five years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 2% on cost and not provided
Plant and machinery etc - 33% on cost and 20% on reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost less any provision for impairment.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


CHEMODEX LIMITED (REGISTERED NUMBER: 02333663)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 33 (2024 - 27 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2024
and 31 March 2025 11,000
AMORTISATION
At 1 April 2024
and 31 March 2025 11,000
NET BOOK VALUE
At 31 March 2025 -
At 31 March 2024 -

CHEMODEX LIMITED (REGISTERED NUMBER: 02333663)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 April 2024 409,539 815,412 1,224,951
Additions 97,000 46,621 143,621
Disposals - (70,110 ) (70,110 )
At 31 March 2025 506,539 791,923 1,298,462
DEPRECIATION
At 1 April 2024 45,008 421,012 466,020
Charge for year 6,122 80,189 86,311
Eliminated on disposal - (25,355 ) (25,355 )
At 31 March 2025 51,130 475,846 526,976
NET BOOK VALUE
At 31 March 2025 455,409 316,077 771,486
At 31 March 2024 364,531 394,400 758,931

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 April 2024
and 31 March 2025 4,000
PROVISIONS
At 1 April 2024
and 31 March 2025 4,000
NET BOOK VALUE
At 31 March 2025 -
At 31 March 2024 -

CHEMODEX LIMITED (REGISTERED NUMBER: 02333663)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 793,859 774,218
Other debtors 60,224 115,137
854,083 889,355

8. CURRENT ASSET INVESTMENTS
2025 2024
£    £   
Listed investments 35,000 35,000

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Hire purchase contracts 54,158 45,730
Trade creditors 799,555 747,349
Taxation and social security 166,808 192,998
Other creditors 32,980 32,787
1,053,501 1,018,864

10. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
2025 2024
£    £   
Hire purchase contracts 140,614 168,663
Other creditors 2,000 26,000
142,614 194,663

11. RESERVES
Fair
Value
Reserve
£   
At 1 April 2024
and 31 March 2025 75,976